Martin Schiestl

Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab

Jan Marinus Visser, Isabel Feuerstein, Thomas Stangler et al. · BioDrugs · 2013 · 179 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

The structure-function relationship of disulfide bonds in etanercept

William C. Lamanna, Robert Ernst Mayer, Alfred Rupprechter et al. · Scientific Reports · 2017 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

The role of the quality assessment in the determination of overall biosimilarity: A simulated case study exercise

Martin Schiestl, Jing Li, Arpah Abas et al. · Biologicals · 2013 · 30 citations

Pharmacy, Quality Management, Bioequivalence +10

Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience?

David Goldsmith, Frank Dellanna, Martin Schiestl et al. · Clinical Drug Investigation · 2018 · 30 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion

William C. Lamanna, Katharina Heller, Daniel Schneider et al. · Journal of Oncology Pharmacy Practice · 2017 · 27 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +16